Duopharma Biotech BhdXKLS:7148 82 Dividend Yield % is 3.79% as of Jun. 26, 2026, which is 40% above its 10-year median of 2.70. GuruFocus rates XKLS:7148 with a GF Score™ of 82/100 and a GF Value™ of RM1.52 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 516 Drug Manufacturers companies, Duopharma Biotech Bhd ranks better than 76.55% on this metric.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Duopharma Biotech Bhd is 3.79%.
Good Sign:
Duopharma Biotech Bhd stock Dividend Yield % is close to 3-year high.
The historical rank and industry rank for Duopharma Biotech Bhd's Dividend Yield % or its related term are showing as below:
XKLS:7148'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.38 Med: 2.7 Max: 4.87
Current: 3.79
During the past 13 years, the highest Dividend Yield of Duopharma Biotech Bhd was 4.87%. The lowest was 1.38%. And the median was 2.70%.
XKLS:7148's Dividend Yield % is ranked better than 76.55% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.03
vs XKLS:7148: 3.79
During the past 12 months, Duopharma Biotech Bhd's average Dividends Per Share Growth Rate was 53.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 15.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -6.80% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -1.10% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Duopharma Biotech Bhd was 25.00% per year. The lowest was -20.60% per year. And the median was -3.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Duopharma Biotech Bhd (XKLS:7148) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Duopharma Biotech Bhd Dividend Yield % Related Terms
Duopharma Biotech Bhd Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Duopharma Biotech Bhd's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7148 vs ZTS, UTHR, VTRS: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Duopharma Biotech Bhd Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Duopharma Biotech Bhd's Dividend Yield % falls into.
Duopharma Biotech Bhd Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Duopharma Biotech Bhd Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
MYR 0.030500
2026-03-12
2026-03-13
2026-03-30
Cash Dividend
semi-annually
MYR:MYR 1.000000
MYR 0.015000
2025-09-08
2025-09-09
2025-09-24
Cash Dividend
semi-annually
MYR:MYR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Duopharma Biotech Bhd's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Duopharma Biotech Bhd (XKLS:7148) has a Dividend Yield % of 3.79% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Duopharma Biotech Bhd and its competitors. This is 40% above median its historical median of 2.70. Over the past decade, Duopharma Biotech Bhd's Dividend Yield % has ranged from 1.38 to 4.87. According to the industry distribution chart, Duopharma Biotech Bhd ranks #121 out of 516 companies in the Drug Manufacturers industry, placing it in the top 23.4%.
Is Duopharma Biotech Bhd's Dividend Yield % too high?
Duopharma Biotech Bhd's current Dividend Yield % of 3.79% is 40% above median its 10-year median of 2.70. Over the past 10 years, this metric has ranged from a low of 1.38 to a high of 4.87. The Drug Manufacturers industry median Dividend Yield % is 2.03. Duopharma Biotech Bhd's value of 3.79% is 86.7% above this industry median. Based on the distribution chart, Duopharma Biotech Bhd ranks #121 out of 516 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Duopharma Biotech Bhd has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Duopharma Biotech Bhd's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Duopharma Biotech Bhd ranks #121 out of 516 companies for Dividend Yield %. This places Duopharma Biotech Bhd in the top 23% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.03. Duopharma Biotech Bhd's value of 3.79% is 86.7% above this benchmark. Historically, Duopharma Biotech Bhd's own Dividend Yield % has ranged from 1.38 to 4.87 over the past decade. While the company's 10-year median is 2.70 vs. the industry median of 2.03, Duopharma Biotech Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.03, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Duopharma Biotech Bhd's current Dividend Yield % of 3.79% is 86.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Duopharma Biotech Bhd and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Duopharma Biotech Bhd's current Dividend Yield % is 3.79%, which is 40% above median its own 10-year median of 2.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Duopharma Biotech Bhd stock overvalued right now?
Based on GuruFocus' analysis, Duopharma Biotech Bhd (XKLS:7148) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.52, compared to a current price of RM1.20 — trading 21.1% below its estimated fair value. The current Dividend Yield % is 3.79%, which is 40% above median its 10-year median of 2.70 and 86.7% above the Drug Manufacturers industry median of 2.03. Duopharma Biotech Bhd's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Duopharma Biotech Bhd (XKLS:7148), the current Dividend Yield % is 3.79% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Duopharma Biotech Bhd (XKLS:7148) Overvalued in 2026?
Based on GuruFocus' analysis, Duopharma Biotech Bhd stock appears to be undervalued.
The current stock price of RM1.20 is trading 21.1% below its estimated GF Value™ of RM1.52.
GuruFocus considers Duopharma Biotech Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7148:
Dividend Yield %: 3.79% (40% above median its 10-year median of 2.70)
GF Value™: RM1.52 vs. price of RM1.20 (21.1% below fair value)
Industry Position: 86.7% above the Drug Manufacturers median (#121 of 516)
No single metric tells the full story. See the XKLS:7148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. The company develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.
82GF Score
Get the complete analysis for XKLS:7148
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7148 has been successfully added to your 
